<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Open Science Publishers LLP</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">94</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>SYNERGISTIC NOOTROPIC EFFECT OF LOW DOSE ASPIRIN AND ONDANSETRON: AN ANIMAL STUDY&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pallavi</surname><given-names>Nema</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sangita</surname><given-names>Totade</given-names></name></contrib><contrib contrib-type="author"><name><surname>C.D</surname><given-names>Gupta</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>30</day><month>11</month><year>2013</year></pub-date><volume>04</volume><issue>03</issue><fpage>14</fpage><lpage>19</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Objective: To evaluate synergistic nootropic effect of low dose aspirin and Ondansetron in rats. Material and Methods: Retention of conditioned avoidance response was assessed using repeated electroconvulsive shock in rats. Electroconvulsive shock was used to induce amnesia. Rats were divided into five groups: control (pretreated with distilled water), Electroconvulsive shock (150 V, 50 Hz sinusoidal with intensity of 210 mA for 0.5 s), combined Electroconvulsive shock and aspirin (7.5mg/kg) pretreated groups, combined Electroconvulsive shock and ondansetron (0.4 mg/kg) pretreated groups, combined Electroconvulsive shock, aspirin (7.5mg/kg) and ondansetron (0.2 mg/kg) pretreated groups. Data was analyzed by ANOVA followed by Dunnet__ampersandsignrsquo;s test. Result: Findings showed that administration of single Electroconvulsive shock daily for consecutive 8 days results in disruption of the retention of conditioned avoidance response. Ondansetron and aspirin significantly prevented Electroconvulsive shock -induced attenuation of the retention of conditioned avoidance response. Combined Aspirin and subnootropic dose of Ondansetron prevented Electroconvulsive shock - induced attenuation of the retention of conditioned avoidance response which is significantly higher than aspirin alone. Conclusion: This study concludes, Aspirin might inhibit this serotonergic transmission and results in its neuroprotective action. When aspirin is combined with 0.2 mg/kg of ondansetron, retention of CAR was significantly higher than aspirin alone.&#13;
</p></abstract><kwd-group><kwd>Conditioned avoidance response</kwd><kwd> Aspirin</kwd><kwd> Ondansetron</kwd><kwd> Electroconvulsive shock</kwd><kwd>  serotonergic transmission.</kwd></kwd-group></article-meta></front></article>
